In previous studies it was shown that transformation of AKR fibroblasts with 3-methylcholanthrene was associated with a loss of surface fibronectin and that induction of differentiation of the transformed cells with N,N-dimethylformamide (DMF) was associated with reacquisition of surface fibronectin (Chakrabarty et al., J. Cell. Physiol. 133:415, 1987). It is shown in the present study that changes in surface fibronectin reflect altered fibronectin synthesis and altered fibronectin binding. Both the nontransformed cells (AKR-2B) and their transformed counterparts (AKR-MCA) bound '"I-fibronectin in a receptor-like fashion, but the AKR-MCA cells had only 20% of the receptors found on the AKR-2B cells. Whole cell extracts prepared from the AKR-2B cells and separated by sodium dodecyl sufatepolyacrylamide gel electrophoresis under reducing conditions were examined for '251-fibronectin binding. Under these conditions, the majority of binding occurred to moieties with molecular weights of 180 kD, 150 kD, and 97 kD. Binding to similar moieties on the AKR-MCA cells was virtually absent but occurred rapidly after treatment with DMF. The appearance of these moieties paralleled the acquisition of '251-fibronectin binding activity by whole cells. Antibodies to the fibronectin receptor isolated from human placenta reacted with the DMF-sensitive moieties in immunoblot assays. Both the appearance of the fibronectin binding moieties and the acquisition of '251-fibronectin binding activity by whole cells occurred within 6 hr of DMF treatment and increased over the subsequent 4 day period. The time course of these events paralleled closely the time course for induction of fibronectin biosynthesis by DMF. These changes in fibronectin binding and fibronectin production were associated with alterations in cell-substrate adhesion. The AKR-26 cells rapidly attached and spread on bovine serum albumin-coated dishes and on fibronectin-coated dishes, whereas the AKR-MCA cells were less adhesive on both substrates. Capacity to attach and spread was regained concomitantly with the induction of fibronectin binding and fibronectin production. Adhesion on both substrates was partially inhibited by antibodies to the fibronectin receptor and by RGDS. These studies suggest that fibronectin production and fibronectin binding are coregulated in AKR fibroblasts and that they function together to bring about changes in cell-substrate adhesion.
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Transformation of rodent cells with a variety of agents (physical, chemical, or viral) results in a dramatic decrease in surface fibronectin (Hynes, 1976; Vaheri and Mosher, 1978; Hayman et al., 1981; Alitalo et al., 1982; Chakrabarty et al., 1987) . It has recently been shown that transformation of rat fibroblasts with a single oncogene (Ha-Ras) has a similar effect (Chakrabarty et al., 1989b) . Loss of surface fibronectin is not unique to rodent cells. In cells of many other species, including humans, malignant variants often have less fibronectin on their surface than their nonmalignant counterparts (Vaheri and Ruoslahti, 1975; Yamada et al., 1978; Smith et al., 1981; TaylorPapadimitriou et al., 1981; Varani et al., 1989) .
Whereas loss of surface fibronectin is a consistent feature of transformation, agents that induce the expression of normal phenotypic characteristics in transformed cells (i.e., differentiation agents) cause the reacquisition of surface fibronectin (Hayman et al., 1980; Milhaud et al., 1980; Carlin et al., 1982; Sporn and Roberts, 1983; Tanaka and Nishida, 1985; Marks et al., 1985; Chakrabarty et al., 1987 Chakrabarty et al., , 1988 Chakrabarty et al., , 1989a Varani et al., 1989) .
What accounts for the alterations in surface fibronectin expression during transformation and differentiation is not fully understood. Alterations either in the production of fibronectin or in fibronectin binding could be responsible. Recent studies with human fibroblasts (Ignotz and Massague, 1987; Roberts et al., 1988) and with murine 3T3 cells (Ryseck et al., 1989) suggest that fibronectin production and fibronectin receptor expression may be coregulated. In the present study we have examined the relationship between fibronectin production and fibronectin binding in murine AKR-2B fibroblasts and their transformed counterparts, AKR-MCA cells. We show here that both fibronectin synthesis and fibronectin binding are reduced in the AKR-MCA cells relative to the AKR-2B cells. It is further shown that treatment of the AKR-MCA cells with N,Ndimethylformamide (DMF), an agent previously shown to induce differentiation of AKR-MCA cells (Chakrabarty et al., 1984 (Chakrabarty et al., , 1985 Levine et al., 1985) and to induce the reexpression of surface fibronectin on these cells (Chakrabarty et al., 1987) , leads to a rapid and concomitant induction of fibronectin synthesis and fibronectin binding. Alterations in fibronectin synthesis and fibronectin binding are directly correlated with alterations in cell-substrate adhesion. Taken together, these data suggest that alterations in adhesive properties that accompany transformation and differentiation of AKR mouse fibroblasts are the result of modulation of surface fibronectin, which in turn results from coordinated alterations in fibronectin synthesis and fibronectin receptor expression.
MATERIALS AND METHODS

Cells
AKR mouse fibroblasts (AKR-2B) and their 3-methylcholanthrene-transformed counterparts (AKR-MCA) were used in this study. Both cell lines were maintained in monolayer culture using McCoy's 5A medium supplemented with 10% fetal bovine serum as culture medium. Growth was at 37°C and 5% COz. The cells were subcultured by trypsinization as required. The AKR-MCA cells were induced to differentiate by treatment with 1% (v/v) DMF in culture medium. The effects of DMF on the biological properties of the AKR-2B and AKR-MCA cells have been described in previous reports (Chakrabarty et al., 1984 (Chakrabarty et al., ,1985 (Chakrabarty et al., ,1987 Levine et al., 1985) .
Reagents
Human plasma fibronectin was obtained from GIBCO (Grand Island, NY), and rabbit polyclonal antifibronectin was obtained from Dako (Santa Barbara, CA). Rabbit polyclonal antibodies to the human fibronectin receptor were obtained from Telios (San Diego, CAI. The synthetic peptide from the cell-binding domain of fibronectin (RGDS) and an inactive control peptide (GRADSP) were obtained from Telios. Analysis of the fibronectin by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions revealed a single band at M, 220-240 kD. It reacted with antifibronectin in enzyme-linked immunosorbent assay (ELISA) at antibody dilutions between 1:l and 1:105 but did not react with rabbit polyclonal antibodies to laminin, thrombospondin, or type IV collagen. Each of these antibody preparations reacted with the appropriate antigen in ELISA. The antifibronectin, likewise, did not react with laminin, thrombospondin, or type IV collagen at any dilution between 1:l and 1:106. The fibronectin stimulated attachment and spreading of a fibronectin-sensitive murine fibrosarcoma cell line at concentrations as low as 0.5 pgi35 mm (diameter) dish.
Biosynthetic labeling Cells were plated in 100 mm (diameter) culture dishes at an approximate density of 5 x lo6 cells per dish. The cells were allowed to attach and spread for 1 hr. They were then treated with 1% DMF (v/v). At various times after DMF treatment, the cells were incubated for 1 hr in culture medium containing 100 pCi/ dish of 35S-methionine (1,000-1,400 pCi/pmole; NEN, Boston, MA). After the 1 hr incubation, the cells were lysed in a solution of phosphate-buffered saline (PBS) containing three detergents (1% Triton X-100,0.5% sodium deoxycholate, and 0.1% SDS; all obtained from Sigma Chemical Co., St. Louis, MO) and protease inhibitors, including 20 mM EDTA, 5 mM N-ethyl maleimide, 2 mM phenylmethylsulfonyl fluoride (PMSF), and 10 ~1 / 1 0 ml of a protease inhibitor cocktail containing: leupeptin, 1 mg/ml; antipain, 2 mg/ml; benzamidine, 10 mg/ml; aprotinin, 10,000 kallikrein-inactivating units/ml; chymostatin, 1 mg/ml; and pepstatin, 1 mg/ml, as described by Ronnett et al. (1984) in studies on the insulin receptor. All the protease inhibitors were obtained from Sigma Chemical Co. The cell lysates were frozen at -80°C, thawed, and clarified by ultracentrifugation (37,OOOg for 60 min). Immunoreactive fibronectin was precipitated with a 1 : l O O dilution of the rabbit antifibronectin and protein A-Sepharose (Sigma Chemical Co.) according to the protocol of Ruddon et al. (1979) . Normal rabbit serum served as a control. The washed immunoprecipitates were eluted with boiling (5 min) in twofold concentrated Laemmli (1970) SDS-PAGE sample buffer containing 2% 2-merceptoethanol. The immunoprecipitated material was fractionated on a 5% polyacrylamide gel employing the Laemmli system. Radioactive bands were visualized by fluorography with En3Hance (NEN), exposing the dried gels to X-ray film (Kodak XAR-2) for 2 days. In addition, a small sample of each immunoprecipitate was counted in a p-scintillation counter to quantitate 35S-methionine incorporation. The amount of radioactivity precipitated with antifibronectin was compared with the amount precipitated with 10% (final) trichloroacetic acid (TCA) to determine the percentage of total synthesized protein accounted for by fibronectin.
Immunoblotting
Whole cell extracts (nonradioactive) were fractionated by SDS-PAGE as described above and immunoblotted with antifibronectin as previously described (Chakrabarty et al., 1987) . Briefly, the proteins fractionated by SDS-PAGE were electrophoretically transferred onto nitrocellulose sheets. The binding profiles of antibodies were assessed as follows. Following transfer, the nitrocellulose sheets were incubated in a blocking solution containing 3% bovine serum albumin, 0.05% Tween 20 in PBS, pH 7.2, a t 4°C overnight. The sheets were then washed once with 1% bovine serum albumin Tween 20 in PBS and incubated with antibodies (1:1,000 dilution) in the same buffer on a gently rocking platform for 3-4 hr a t room temperature. The sheets were washed four times with 1% bovine serum albumin Tween 20 and incubated with the same buffer containing 500,000 cpm 1251-protein A (ICN, Irvine, CAI overnight on a gently rocking platform at room temperature. Following incubation, the sheets were washed several times in PBS containing 0.05% Tween 20 and air dried. The binding of antibodies and lz5I-protein A to the antigens on the nitrocellulose sheets was visualized by autoradiography. As controls, other nitrocellulose sheets containing the transferred proteins were similarly treated with normal rabbit serum (1:1,000 dilution) or with '251-protein A in the absence of antibodies. No 1251-protein A binding was observed in the controls. Whole cell extracts were examined for binding of antibodies to the fibronectin receptor in the same manner.
ELISAs
ELISAs were used to quantitate the amount of immunoreactive fibronectin secreted into the culture medium. For this, cells were plated a t 3 x lo5 cellddish in 35 mm (diameter) cell culture dishes. Cells were allowed to attach and spread for l hr. Following this, the cells were washed two times in serum-free culture medium and incubated with serum-free McCoy's 5A medium supplemented with 200 pg/ml of bovine serum albumin. DMF (1% v/v) was added to one-half the wells. At various times later, 200 p1 of each culture fluid was added to wells of a 96-well plate (Falcon Plastics, Oxnard, CA) from lots that had been prescreened for acceptability in ELISA reactions and incubated for 4 hr at 37°C. Culture medium alone served as a control.
Purified human plasma fibronectin (0.5-0.0005 pgl well) was also added to the assay plate in the same culture medium to serve as a standard. After the 4 hr incubation, the fluids were removed from the wells, and the assays were run exactly as described previously (Varani et al., 1983) .
'251-fibronectin binding assay Fibronectin was iodinated with NalZ5I (Amersham, Arlington Heights, IL) using the chloramine T method to a specific activity of approximately 1 pCi/pg. Unreacted NalZ5I was removed from the protein by gel filtration chromatography on Biogel P-10 (LKB, Uppsala, Sweden). Binding assays were performed as previously described, with some modifications (Riser et al., 1988; Chakrabarty et al., 1989b) . Cells (3 x lo5) were seeded into 24-well culture dishes in McCoy's 5A medium containing 10% fetal bovine serum and incubated overnight at 37°C and 5% COP in a humidified incubator. The cells in monolayer were then washed twice with binding medium (serum-free McCoy's 5A medium containing 20 mM Hepes, pH 7.4, and 500 pg of bovine serum albumin/ml) and incubated for a n additional 2 h r at 37°C and 5% CO, in binding medium. Following this, the binding medium was removed and appropriate amounts of 1251-labeled fibronectin in fresh binding medium in the presence or absence of 100-fold excess of unlabeled fibronectin was added. The cells were incubated at 37°C and 5% COz for 1 h r and then washed four times in binding medium, with gentle shaking on a horizontal shaker. Following the last wash, the cells were detached from the culture dishes by trypsinization at 37"C, and the entire contents were transferred to test tubes for counting. The culture wells were rinsed once with the trypsin solution, which was then combined with corresponding test tubes for counting. All assays were performed in triplicate, with parallel cultures used to determine cell number. The amount of radioactivity specifically bound was determined by the following formula. '251-fibronectin binding to cell lysates Cells were grown in 100 mm (diameter) dishes to an approximate density of 7.5 x lo6 cellddish. Cells extracts were prepared as described previously (Chakrabarty et al., 1987) and separated by SDS-PAGE under reducing conditions. The proteins were electrophoretically transferred onto nitrocellulose sheets. The binding profile of 1251-fibronectin was assessed as follows. Following transfer, the nitrocellulose sheets were incubated in a blocking solution containing 3% bovine serum albumin, 0.05% Tween 20 in PBS, pH 7.2, at 4°C overnight. The sheets were then washed once with 1% bovine serum albumin Tween 20 in PBS and incubated with 1251-fibronectin (8 nM) with and without a 100-fold excess of unlabeled fibronectin in the same buffer on a gently rocking platform for 3-4 h r a t room temperature. The sheets were washed four times with 1% bovine serum albumin Tween 20. Following incubation, the sheets were washed several times in PBS containing 0.05% Tween 20 and air dired. The binding of 1251-fibronectin was visualized by autoradiography using Kodak XAR-2 film. This procedure has been used previously by others to identify fibronectin-binding and laminin-binding moieties (Codogno et al., 1987; Kleinman et al., 1988) .
Adhesion assay Cells were examined for attachment and spreading on plastic culture dishes in the presence of bovine serum albumin. The cells were harvested from culture, washed twice in serum-free medium, and added to the wells of a 24-well cluster dish (3 x lo5 cells per well) in serum-free medium supplemented with 200 pg/ml of bovine serum albumin. The wells were incubated at 37"C, and, at various times later, the nonattached cells were removed and counted. The wells were then flooded with 2% glutaraldehyde, and the percentage of spread cells was assessed microscopically. By combining the two values, a percentage of the originally added cells that were attached and spread a t each time point was obtained. In some experiments, wells were treated for 2 hr with human plasma fibronectin prior to use. The adhesion assay was then carried out in the same manner.
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RESULTS
Fibronectin-binding by AKR-2B and AKR-MCA-cells Our previous studies showed that the AKR-2B cells were much more adhesive to fibronectin than the AKR-MCA cells and that DMF induced adhesion to fibronectin in the AKR-MCA cells (Chakrabarty et al., 1987) . It was of interest, therefore, to determine if differences in response to fibronectin were related to differential fibronectin binding capacity. To determine this, we used a 1251-fibronectin-binding assay to compare AKR-2B and AKR-MCA cells. With both cell lines, binding of 1251-fibronectin occurred in a receptor-like fashion. That is, binding was concentration-dependent, saturable, and inhibitable with excess unlabeled fibronectin. Binding curves for both cell lines are shown in Figure  1 . It can be seen that the number of binding siteskell distinguished the two cell lines. We estimated that 25% of the total binding, was determined in the presence of 100-fold excess unlabeled fibronectin and has been subtracted from each data point. The experiment was repeated three times with similar results.
B-D Scatchard analysis of the binding data.
there were 8.0 x lo4 binding siteslAKR-2B cell and 2.0 x lo4 sites/AKR-MCA cell. In addition, the average affinity of binding was slightly greater to the AKR-2B than AKR-MCA cells (Kd 22 vs. 45 nM) (Fig. 1) . Effects of DMF on 1251-fibronectin binding by the AKR-MCA cells was examined next. As can be seen in Figure 1 , treatment of the AKR-MCA cells with 1% DMF for 4 days stimulated fibronectin binding in these cells to a level comparable to that observed with the AKR-ZB cells. The same treatment had only minimal effect on fibronectin binding by the AKR-2B cells (not shown).
To examine the time course of DMF-mediated changes in fibronectin binding, AKR-MCA cells were plated in wells of a 24-well dish and incubated for varying periods of time with 1% DMF. 1251-fibronectin binding studies were then carried out in the normal manner using a single concentration of fibronectin (8 nM). DMF treatment induced a detectable increase in fibronectin binding by the AKR-MCA cells as early as 6 hr after treatment. The increase continued over the following 3 days (Table 1) . We next examined binding of 1251-fibronectin to whole cell extracts prepared from AKR-2B and AKR-MCA cells by detergent lysis. Control cells and cells treated with 1% DMF for varying periods of time were lysed and separated by electrophoresis on a 7.5% SDSpolyacrylamide gel under reducing conditions. The separated proteins were then transferred to nitrocellulose as described in Materials and Methods and probed with 1251-fibronectin. Figure 2 shows the pattern typically seen after autoradiography. Distinct binding moieties at Mr 180 kD, 150 kD, and 97 kD were visible in the extracts prepared from the AKR-2B cells (lane 6). Binding was specific in that 100-fold excess of unlabeled fibronectin completely inhibited binding (lane 7). In contrast to the results obtained with AKR-2B cells, there was almost no binding to extract proteins from the untreated AKR-MCA cells (lane 1). Binding was seen in these cells, however, after treatment with DMF. Bands could be seen as early as 6 h r after treatment (not shown) and were clearly distinct by 1 day after treatment (lane 2). The bands increased in density over the following 3 days (lanes 3-5) so that by day 4 they were essentially as dark as the bands from the AKR-2B cells. A small but significant amount of binding was also observed to moieties in the range of 50-60 kD .
The relationship between these fibronectin-binding moieties and the well-characterized integrin receptor for fibronectin is not known. To address this issue, we examined binding of rabbit polyclonal antibodies prepared against the human fibronectin receptor from placenta by whole cell extracts of the AKR-2B and AKR-MCA cells. Antibody binding and detection was done as described in Materials and Methods. As is shown in Figure 3 , antibodies to the fibronectin receptor exhibited a broad band of reactivity in the 150-180 kD range with extract from the AKR-2B cells (lane 3). Antibody binding to this region of the gel was absent with extract from control AKR-MCA cells (lane 1) but was seen in extract prepared from AKR-MCA cells one day after treatment with 1% DMF (lane 2). In addition to binding in this region of the gel, the antifibronectin antibody reacted with moieties in the 97 kD region of the gel and with lower molecular weight bands. Binding to these moieties, however, did not distinguish extracts from three populations. Effects of DMF on fibronectin production b y AKR-MCA cells In our previous studies (Chakrabarty et al., 1987) we showed that fibronectin production was lower in AKR-MCA cells than in AKR-2B cells and that it was stimulated in AKR-MCA cells by treatment with DMF for 4 days. We have in the present study examined the time course of fibronectin production in DMF-treated AKR-MCA cells. Biosynthetic labeling/immunoprecipitation was used in the first series of experiments. Table 2 shows the time course of DMF-induced changes in total incorporation of 35S-methionine into 10% TCAprecipitable material (a measure of protein synthesis). Cells treated for 2 or 4 hr with DMF were not significantly different from control cells. Reduced incorporation was observed by 5 hr (approximately 20% reduction vs. untreated AKR-MCA cells examined in the same manner) and continued through 24 hr. After 24 hr, total incorporation of 35S-methionine into TCA-precipitable material from cultures of DMF-treated cells was only 28% of the amount incorporated into TCAprecipitable material from control cultures. On a per cell basis, total incorporation into TCA-precipitable material was reduced by approximately 50% in the treated cells compared with control cells. Table 2 also shows the effect of DMF treatment on incorporation of 35S-methionine into antifibronectinprecipitable material. Increased fibronectin biosynthesis (as a function of total protein synthesis) was de- of nonfibronectin proteins. Examination of antifibronectin-precipitated material from the DMF-treated AKR-MCA cells by SDS-PAGE under reducing conditions and autoradiography revealed a closely spaced doublet with molecular weights of 220-240 kD. Identical forms were seen in extracts of the AKR-2B and AKR-MCA cells (not shown). Thus there appeared to be no qualitative changes in the molecular forms of fibronectin produced in response to DMF.
Immunoblotting was used as a second means of visualizing changes in fibronectin production. Whole cell extracts were separated by SDS-PAGE and immunoblotted as described in Materials and Methods. 2 hr after DMF treatment showed slightly increased amounts of fibronectin. Culture fluids obtained 6 hr or more after treatment showed significantly increased amounts ( Table 3) .
Effects of DMF on AKR-MCA cell adhesion We knew from our previous studies that the AKR-2B cells rapidly attached and spread on bovine serum altected by 6 hr. The percentage increase in fibronectin production was much greater than the percentage decrease in total protein synthesis a t 6, 8, and 24 hr, indicating that the increase reflected actual increases in fibronectin synthesis as well as decreased synthesis (4 bumin-coated dishes, whereas the AKR-MCA cells attached and spread much more slowly (Chakrabarty et al., 1987) . That the rapid adhesion response of the AKR-2B cells was due to surface fibronectin was strongly suggested by the finding that antibody to fibronectin but not to laminin inhibited this response. We therefore sought to determine in the present study if changes in AKR-MCA cell adhesion would parallel changes in fibronectidfibronectin receptor expression following DMF treatment. Cells were grown in monolayer culture and treated with 1% DMF for varying periods of time. At the end of the treatment period, the cells were harvested by trypsinization and assayed for attachment and spreading on bovine serum albumincoated dishes as described in Materials and Methods. AKR-MCA cells pretreated with DMF for 3 hr (but not for 1 or 2 hr) showed increased adhesion over untreated AKR-MCA cells. Increased attachment and spreading was detected by 2 hr (total elapsed time of 5 hr since treatment) (Fig. 5A) . The change in adhesion induced by DMF parallels, therefore, changes in fibronectin production and fibronectin receptor expression.
AKR-MCA cells were also examined for alterations in adhesion to fibronectin following treatment with DMF. Alterations in adhesion to fibronectin paralleled alterations in adhesion to plastic culture dishes in the presence of bovine serum albumin (Fig. 5B) . That is, cells treated for 3 hr with 1% DMF attached and spread on fibronectin (10 pg) coated dishes more rapidly than untreated AKR-MCA cells.
In additional experiments, antibodies to the human fibronectin receptor and the synthetic peptide RGDS from the cell-binding domain of fibronectin were examined for effects on AKR-MCA cell adhesion. AKR-MCA cells that had been incubated for one day with 1% DMF were treated with the antifibronectin antibody or with RGDS and added to untreated or fibronectin-treated wells of a plastic culture dish. Normal rabbit serum and the synthetic peptide GRADSP served as controls. Attachment and spreading were measured in the normal way. Table 4 shows that both the antibody to the fibronectin receptor and the synthetic peptide RGDS partially inhibited AKR-MCA cell adhesion. Adhesion on untreated dishes and on fibronectin-coated dishes was inhibited equally by both reagents. The two control reagents did not inhibit adhesion (Table 4) . DISCUSSION Transformation of cells is associated with a loss of surface fibronectin (Hynes, 1976; Vaheri and Mosher, 1978; Hayman et al., 1981; Alitalo et al., 1982; Chakrabarty et al., 1987 Chakrabarty et al., , 1989b . Reacquisition of the normal phenotype following treatment with chemical differentiation agents is associated with the reexpression of surface fibronectin (Hayman et al., 1980; Milhaud et al., 1980; Charkrabarty et al., 1987 Charkrabarty et al., , 1988 Charkrabarty et al., , 1989a Varani et al., 1989) . What underlies the alteration in fibronectin expression during transformation and differentiation is not fully understood. Reduced fibronectin biosynthesis is at least partially responsible (Olden and Yamada, 1977; Smith et al., 1981; Taylor-Papadimitriou et al., 1981; Oliver et al., 1983; Senger et al., 1983; Tanaka and Nishida, 1985; 1987,1989b). However, a reduction in fibronectin synthesis has not been observed in all transformed cells (Vaheri and Ruoslahti, 1975 ). An alternative explanation to account for the reduced surface fibronectin expression in transformed cells is a reduction in capacity of the transformed cells to bind fibronectin. The fibronectin receptor has been identified on a number of different cell types as a member of the integrin family of adhesion receptors (Pytela et al., 1985; Pate1 and Lodish, 1986; Giancotti et al., 1986a,b; Cadarelli and Pierschbacher, 1987; Codogno et al., 1987; Confarti et al., 1989; Kerjaschki et al., 1989) . Plantefaber and Hynes (1989) recently reported that the fibronectin receptor was decreased on several transformed rodent cells compared with their normal counterparts. They suggested that decreased fibronectin binding rather than decreased fibronectin production was probably the key factor underlying the reduced level of surface fibronectin expression on transformed cells. They also argued that altered fibronectin binding (rather than reduced fibronectin production) was probably critical to the alterations in adhesion that accompany transformation.
In the present study we have examined the relationship between fibronectin production and fibronectin binding in transformed AKR fibroblasts under control conditions and during induction of differentiation with DMF. DMF has been shown in previous studies to reverse the transformed phenotype in these cells (Chakrabarty et al., 1984 (Chakrabarty et al., , 1985 (Chakrabarty et al., , 1987 Levine et al., 1985) . The present data indicate that both fibronectin production and fibronectin binding are greatly reduced in 3-methylcholanthrene-transformed AKR cells compared with their nonmalignant counterpart (AKR-2B) cells and that both are stimulated rapidly in the transformed cells (within 5-6 hr) after treatment with DMF. We had originally hoped to utilize the time course data to determine the sequence of events that occurred following DMF treatment, i.e., to determine if changes in fibronectin production occurred prior to alterations in fibronectin binding or whether changes in binding preceeded changes in fibronectin production. These data could prove useful in efforts to understand the relationship between fibronectin production and up-regulation of its receptor. However, the similarities in the time courses for stimulation of fibronectin production and fibronectin binding do not allow us to do this. They do allow us to suggest that the two events are closely linked in the AKR cells. A similar conclusion was reached by Ignotz and Massague (1987) and by Roberts et al. (1988) in their studies on human fibroblasts treated with transforming growth factor-p (TGF-P) and by Ryseck et al. (1989) in their studies on serum-stimulated fibroblasts.
The nature of the DMF-sensitive, fibronectin-binding moieties associated with the AKR cells was not delineated in the present study. When cell extracts (separated by SDS-PAGE under reducing conditions) were examined for fibronectin binding on nitrocellulose, the majority of binding occurred to moieties with apparent molecular weights of 180, 150, and 97 kD. It is possible that these moieties represent subunits of the integrin receptor for fibronectin. Alternatively, since we used extracts prepared from whole cells, it is possible that much of the binding occurred to proteins that are not present in the mature cell surface receptor. Whether these moieties are related to the mature cell surface receptor is not clear. Additional studies will be needed to determine if this is the case. If it turns out that the moieties responsible for fibronectin binding in the whole cell extract are related to the integrin receptor for fibronectin, this will be of interest in light of previous observations showing that the integrin complex from chick fibroblasts does not bind fibronectin under denaturing conditions (Buck et al., 1986) .
These experiments do not definitively show that the fibronectin binding moieties present in the whole cell extracts are members of the integrin family. It is clear, however, from the studies with the antifibronectin receptor that the AKR cell extracts contain a moiety that is immunologically cross reactive with the fibronectin receptor. This moiety was detected in the extracts from the normal cells, was virtually absent in the extract from the transformed cells, and reappeared rapidly after DMF treatment of the transformed cells. The loss of this moiety after transformation and reappearance after treatment with DMF correlated with changes in fibronectin binding in the whole cell binding assay and also correlated with changes in cell-substrate adhesion under the same conditions. This is consistent, therefore, with the suggestion that the immunologically cross reactive moiety is responsible for fibronectin binding by the AKR cells and for the attendant biological activity. The finding that the same antibody, as well as RGDS, was able to inhibit the adhesion response is also supportive.
In addition to examining the relationship between fibronectin production and fibronectin binding, we also sought to delineate the relationship between both fibronectin production and binding on the one hand and cell-substrate adhesion on the other. It is clear from our data that the alterations in fibronectin production and fibronectin binding that accompany transformation and differentiation are closely associated with altered cell-substrate adhesion in the AKR cells. The transformed cells were less adherent than their untransformed counterparts to fibronectin and increased adhesion to this substrate occurred in concert with the reexpression of fibronectin binding capacity following DMF treatment. Interestingly, changes in adhesion to plastic culture dishes in the presence of bovine serum albumin paralleled changes in adhesion to fibronectin. This most likely reflects altered fibronectin synthesis as well as fibronectin receptor expression. Antibodies to the fibronectin receptor as well as the synthetic peptide RGDS were effective in inhibiting adhesion to the plastic culture dishes in the presence of bovine serum albumin. These data strongly support the idea that altered adhesion is a reflection of changes in both fibronectin synthesis and fibronectin binding. Based on these data and our previous data (Chakrabarty et al., 1987 , we believe that the initial adhesion of rodent fibroblasts in culture (at least under serum-free conditions) is mediated through endogenously synthesized fibronectin interacting with cell surface fibronectin receptors. Since these receptors are directly linked to cytoskeletal elements (Chen et al., 1985; Damski et al., 1985) , the interaction of ligand and receptor could lead to cytoskeletal reorganization and modulation of cell morphology as well as to the initial attachment of the cells to the substratum.
It should be noted that decreased fibronectin receptor expression on transformed rodent fibroblasts is not indicative of a general loss of integrins. Plantefaber and Hynes (1989) noted that several integrins capable of binding fibronectin were present on transformed rodent cells in spite of the loss of the specific fibronectin receptor. Likewise, Giancotti et al. (1986a,b) observed that Rows sarcoma virus (RSVI-transformed fibroblasts as well as control cells stained with an antibody to the integrin complex. Qualitative rather than quantitative differences in the staining patterns were seen. Furthermore, the fibronectin receptor itself is not decreased on all cells during transformation. Saga, Chen, and Yamada (1988) found increased expression of fibronectin receptors on fibrocytic tumors induced in chickens by RSV. Similar or increased levels of antifibronectin immunostaining have also been noted on the surface of transformed human cells relative to their nontransformed counterparts (Akiyama et al., 1990) . Thus decreased ability to utilize fibronectin or other matrix components is not a necessary consequence of transformation.
Studies from several laboratories have shown that rodent cells express receptors for laminin (Malinoff and Wicha, 1983; Rao et al., 1983; Kramer et al., 1989; Chakrabarty et al., 1989b) . These cells also synthesize laminin (Varani et al., 1983; Chakrabarty et al., 1987 Chakrabarty et al., , 1989b . Thus it is possible that interaction of laminin and its receptor are involved in mediating the adhesion of rodent fibroblasts to their substratum. However, our studies with the AKR fibroblasts (Chakrabarty et al., 1987) suggest that adhesion mediated through laminin probably does not play an important role in the initial attachment of these cells to the substratum. Evidence for this includes the fact that antibodies to laminin do not interfere with attachment and spreading of the untransformed cells on bovine serum albumin-coated dishes and the fact that the transformed cells express as much (or greater amounts of) surface laminin as the untransformed cells, yet are defective in their initial attachment and spreading. Furthermore, the untransformed AKR cells produce much less laminin than fibronectin. and it accumulates much more slawlv. Thiis it is unlikely that laminin plays a major role in the initial adhesion process when the cells concomitantly produce much larger amounts of fibronectin and express surface receptors for fibronectin. Although probably not involved in the initial adhesion response, laminin-laminin receptor interaction may promote adhesion a t later time points. Although they are defective in their initial attachment, transformed AKR fibroblasts (Chakrabarty et al., 1987) as well as other transformed rodent fibroblasts (Varani et al., 1983 (Varani et al., , 1985 Chakrabarty et al., 1989b ) that express laminin on their surface are capable of attaching and spreading on plastic culture dishes at longer time periods. In contrast, cells that are defective in both fibronectin and laminin are deficient in their initial rates of attachment and in attachment at later time points (Varani et al., 1983 (Varani et al., , 1985 . Whether these in vitro observations have in vivo counterparts is not known. However, the existance of multiple mechanisms of adhesion could explain how malignant cells might demonstrate the reduced adhesiveness necessary to allow cells to separate from the primary tumor and yet have the capacity to adhere to endothelial cells or to subendothelial basement membranes at secondary sites during the process of metastasis.
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